Alloscardovia omnicolens
| Alloscardovia omnicolens | |
|---|---|
| Scientific classification | |
| Domain: | Bacteria |
| Kingdom: | Bacillati |
| Phylum: | Actinomycetota |
| Class: | Actinomycetes |
| Order: | Bifidobacteriales |
| Family: | Bifidobacteriaceae |
| Genus: | Alloscardovia |
| Species: | A. omnicolens |
| Binomial name | |
| Alloscardovia omnicolens (Huys et al. 2007)[1] | |
Alloscardovia omnicolens is a Gram-positive, rod-shaped bacterium within the family Bifidobacteriaceae that has been isolated from a number of human clinical samples.[1] Though typically thought to be commensal in humans, A. omnicolens may be associated with urinary tract infections.[2][3][4]
Etymology
The genus name Alloscardovia comes from "allos", the Greek word for different, and "Scardovia", the name of a closely-related bacterial genera.[1] This aligns with the naming convention of other relatives, Scardovia, Aeriscardovia, and Parascardovia.[1] Omnicolens derives from "omnis", Latin for every and "colens", Neo-Latin for dwelling, because A. omnicolens dwells in many places in the human body.[1]
Taxonomy and phylogenetics
Alloscardovia omnicolens was previously classified as an atypical member of the Bifidobacterium genus.[1] Huys et al. 2007 reclassified A. omnicolens within the new genus Alloscardovia, one of nine genera within the family Bifidobacteriaceae.[5] This organism's closest relatives are other members of Alloscardovia, which also includes A. criceti, A. macacae, A.venturai, and A. theropitheci.[6][7][8] 16s rRNA analysis, or comparison of the sequence of the small, highly conserved gene that codes for the 16s subunit of the ribosome, shows that A. omnicolens shares 96%-97.8% similarity with other members of the genus; its closest relative is A. criceti at 97.8% similarity.[6][7][8] Other closely related species include Parascardovia denticolens and Scardovia inopinata, which share 93.0-93.2% and 92.9-93.1% 16s rRNA similarity, respectively.[1]
Discovery
Alloscardovia omnicolens was proposed as the type species for Alloscardovia as the first discovered species of its genus in 2007 following analysis of twelve isolated samples collected from tonsils, urethra, urine, and blood.[1] The researchers were based in Belgium and Sweden at Ghent University, University of Göteborg, and University of Louvain at the time of publication.[1]
Isolation
Huys et al. isolated and identified the Alloscardovia genus, along with specific species within the genus.[1] Researchers obtained the strains from clinical samples at the University of Göteborg.[1] Although the clinical samples were collected across decades (from 1978 to 2005), isolation and analysis of the samples and publication of findings did not occur until 2007.[1] The strains were grown on modified Columbia agar plates with special peptone, starch, sodium chloride, and L-cysteine hydrochloride for isolation.[1]
Methodology
The isolated strains were compared to known Bifidobacterium strains.[1] The first method for comparison involved repetitive PCR fingerprinting,[1] a process where primers, markers that target specific DNA sequences, form visual bands in gel electrophoresis that are used to compare DNA from various strains.[9] The results from two primers provided evidence that the isolated strains were not Bifidobacterium.[1] Potential phylogenetic trees were constructed by sequencing the genes for 16s rRNA and HSP60, another highly conserved protein that protects against protein misfolding in high heat.[1][10][11] Lastly, DNA-DNA hybridization, a method where different strains' DNA is tested for similarity,[12] yielded results that supported the four selected strains were the same species, which was named Alloscardovia omnicolens.[1]
Growth conditions
Unlike some members of the Bifidobacteriaceae family, A. omnicolens is able to grow under aerobic conditions, although anaerobic conditions are optimal.[1] In anaerobic conditions, growth occurred after 24 hours on modified Columbia agar.[1] Contrastingly, it took 72 hours for bacterial growth in aerobic conditions.[1] A. omnicolens can grow at as low as 28 °C, optimally grows at 37 °C, and cannot grow at 50 °C.[1]
Metabolism
All Alloscardovia species can ferment glucose, aesculin, salicin, maltose, melibiose, sucrose and raffinose, which differentiates them from other Bifidobacteriaceae.[8] Fermentation of L-arabinose, raffinose, salicin, and D-xylose results in acid production, unique to A. omnicolens compared to other Bifidobacteriaceae.[1] Alloscardovia species do not possess the catalase enzyme,[1] meaning they cannot break down hydrogen peroxide.[13] A. omnicolens is positive for β-galactosidase,[1] an enzyme that breaks down lactose.[14]
Genomics
The reference genome of A. omnicolens from NCBI indicates a size of 1.8Mbp.[15] A. omnicolens has 1,616 genes, with 1,528 of them coding for proteins.[15] According to Huys et al., the G+C content of A. omnicolens DNA is between 47.3 and 48.3%mol.[1] The G+C content of an organism is the amount of guanine and cytosine bases in the DNA sequence, increased amounts may indicate more stability.[16] Killer et al. obtained the same results as Huys et al. for the species and concluded that the Alloscardovia genus has a range of 47.3 to 53%mol across three different species: A. omnicolens, A. macacae, and A. criceti.[6]
Ecology
Members of the Bifidobacteriaceae family are predominantly located in animal hosts.[17] Bifidobacteriaceae ferment carbohydrates in the gastrointestinal tract, a potentially beneficial quality for their hosts' digestion.[17] Since its discovery in 2007, A. omnicolens has been isolated only from human clinical samples, such as urine, tonsils, lungs, and the oral cavity.[1][18] This is consistent with its family classification and indicates that the bacteria primarily survives in the human body.[18] Research on the role of A. omnicolens in the human body has considered it commensal for the GI tract and oral cavity,[18] a relationship where the bacteria populate their human host without causing harm.[19] However, some research suggests A. omnicolens has a role in causing urinary tract infections.[2][3]
Clinical significance
A. omnicolens has been identified in samples from various locations of the human body, including the oral cavity, the urethra, urine, blood, and abscesses of the lung and the aortic valve.[1] This organism is often thought to be a normal flora of the human oral cavity, gastrointestinal tract, and urogenital tract, but may play a pathogenic role in urinary tract infections.[2][3][4] Of known instances of pure or predominant growth of A. omnicolens in urine cultures, some have co-occurred with UTIs.[2][3] In a small number of those instances, A. omniocolens was identified as a possible or probable causative agent for the infection.[2][3] The majority of clinical cases involving this organism have been in women, giving it special importance as an agent in women's health.[2][4] Additionally, Ogawa et al. 2016 reported the first known case of bacteremia caused by A. omnicolens in a 70-year-old female patient with a urinary tract infection.[4] Further study is needed in order to determine the true clinical significance of this organism in relation to UTIs, but its presence in urine cultures of patients with possible urinary tract infections, especially in female patients, should be carefully considered by clinicians.[2][3]
References
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Huys, Geert; Vancanneyt, Marc; D'Haene, Klaas; Falsen, Enevold; Wauters, Georges; Vandamme, Peter (2007). "Alloscardovia omnicolens gen. nov., sp. nov., from human clinical samples". International Journal of Systematic and Evolutionary Microbiology. 57 (7): 1442–1446. doi:10.1099/ijs.0.64812-0. ISSN 1466-5034. PMID 17625172.
- 1 2 3 4 5 6 7 Brown, Melanie K.; Forbes, Betty A.; Stitley, Kristin; Doern, Christopher D. (2016-05-23). "Defining the Clinical Significance of Alloscardovia omnincolens in the Urinary Tract". Journal of Clinical Microbiology. 54 (6): 1552–1556. doi:10.1128/jcm.03084-15. PMC 4879285. PMID 27053667.
- 1 2 3 4 5 6 Mahlen, Steven D.; Clarridge, Jill E. (2009). "Site and Clinical Significance of Alloscardovia omnicolens and Bifidobacterium Species Isolated in the Clinical Laboratory". Journal of Clinical Microbiology. 47 (10): 3289–3293. doi:10.1128/jcm.00555-09. PMC 2756926. PMID 19641056.
- 1 2 3 4 Ogawa, Yoshihiko; Koizumi, Akira; Kasahara, Kei; Lee, Sang-Tae; Yamada, Yuki; Nakano, Ryuichi; Yano, Hisakazu; Mikasa, Keiichi (2016-06-01). "Bacteremia secondary to Alloscardovia omnicolens urinary tract infection". Journal of Infection and Chemotherapy. 22 (6): 424–425. doi:10.1016/j.jiac.2015.12.013. ISSN 1341-321X. PMID 26829996.
- ↑ Lugli, Gabriele Andrea; Milani, Christian; Turroni, Francesca; Duranti, Sabrina; Mancabelli, Leonardo; Mangifesta, Marta; Ferrario, Chiara; Modesto, Monica; Mattarelli, Paola; Jiří, Killer; van Sinderen, Douwe; Ventura, Marco (2017). "Comparative genomic and phylogenomic analyses of the Bifidobacteriaceae family". BMC Genomics. 18 (1) 568. Bibcode:2017BMCG...18..568L. doi:10.1186/s12864-017-3955-4. ISSN 1471-2164. PMC 5540593. PMID 28764658.
- 1 2 3 Killer, J.; Ročková, Š.; Vlková, E.; Rada, V.; Havlík, J.; Kopečný, J.; Bunešová, V.; Benada, O.; Kofroňová, O.; Pechar, R.; Profousová, I. (2013). "Alloscardovia macacae sp. nov., isolated from the milk of a macaque (Macaca mulatta), emended description of the genus Alloscardovia and proposal of Alloscardovia criceti comb. nov". International Journal of Systematic and Evolutionary Microbiology. 63 (Pt_12): 4439–4446. doi:10.1099/ijs.0.051326-0. ISSN 1466-5034. PMID 23907220.
- 1 2 Modesto, Monica; Satti, Maria; Watanabe, Koichi; Sciavilla, Piero; Felis, Giovanna E.; Sandri, Camillo; Spiezio, Caterina; Arita, Masanori; Mattarelli, Paola (2019-10-01). "Alloscardovia theropitheci sp. nov., isolated from the faeces of gelada baboon, the 'bleeding heart' monkey (Theropithecus gelada)". International Journal of Systematic and Evolutionary Microbiology. 69 (10): 3041–3048. doi:10.1099/ijsem.0.003584. ISSN 1466-5026. PMID 31395120.
- 1 2 3 Sechovcová, Hana; Killer, Jiri; Pechar, Radko; Geigerová, Martina; Švejstil, Roman; Salmonová, Hana; Mekadim, Chahrazed; Rada, Vojtěch; Vlková, Eva; Kofroňová, Olga; Benada, Oldřich (2017-08-01). "Alloscardovia venturai sp. nov., a fructose 6-phosphate phosphoketolase-positive species isolated from the oral cavity of a guinea-pig (Cavia aperea f. porcellus)". International Journal of Systematic and Evolutionary Microbiology. 67 (8): 2842–2847. doi:10.1099/ijsem.0.002031. ISSN 1466-5026. PMID 28820091.
- ↑ Ishii, Satoshi; Sadowsky, Michael J. (2009). "Applications of the rep-PCR DNA fingerprinting technique to study microbial diversity, ecology and evolution". Environmental Microbiology. 11 (4): 733–740. Bibcode:2009EnvMi..11..733I. doi:10.1111/j.1462-2920.2008.01856.x. ISSN 1462-2920. PMID 19207574.
- ↑ Church, Deirdre L.; Cerutti, Lorenzo; Gürtler, Antoine; Griener, Thomas; Zelazny, Adrian; Emler, Stefan (2020-09-09). "Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory". Clinical Microbiology Reviews. 33 (4): 10.1128/cmr.00053–19. Bibcode:2020CliMR..3353.19C. doi:10.1128/cmr.00053-19. PMC 7484979. PMID 32907806.
- ↑ Goh, S H; Potter, S; Wood, J O; Hemmingsen, S M; Reynolds, R P; Chow, A W (1996). "HSP60 gene sequences as universal targets for microbial species identification: studies with coagulase-negative staphylococci". Journal of Clinical Microbiology. 34 (4): 818–823. Bibcode:1996JCMb...34..818G. doi:10.1128/jcm.34.4.818-823.1996. PMC 228899. PMID 8815090.
- ↑ Rosselló-Móra, Ramon; Urdiain, Mercedes; López-López, Arantxa (2011-01-01), "15 - DNA–DNA Hybridization", in Rainey, Fred; Oren, Aharon (eds.), Methods in Microbiology, Taxonomy of Prokaryotes, vol. 38, Academic Press, pp. 325–347, doi:10.1016/b978-0-12-387730-7.00015-2, ISBN 978-0-12-387730-7, retrieved 2025-04-16
- ↑ Singh, Poonam; Kumar, Sanjay (2019-01-01), "Chapter 2 - Microbial Enzyme in Food Biotechnology", in Kuddus, Mohammed (ed.), Enzymes in Food Biotechnology, Academic Press, pp. 19–28, ISBN 978-0-12-813280-7, retrieved 2025-05-07
- ↑ Sindhu, Raveendran; Shiburaj, Sugathan; Sabu, A.; Fernandes, Pedro; Singhal, Rekha; Mathew, Gincy Marina; Nair, Indu C.; Jayachandran, K.; Vidya, Jalaja (2021-01-01), "3.12 - Enzyme Technology in Food Processing: Recent Developments and Future Prospects", in Knoerzer, Kai; Muthukumarappan, Kasiviswanathan (eds.), Innovative Food Processing Technologies, Oxford: Elsevier, pp. 191–215, ISBN 978-0-12-815782-4, retrieved 2025-05-07
- 1 2 "Alloscardovia omnicolens DSM 21503 genome assembly ASM42050v1". NCBI. Retrieved 2025-04-16.
- ↑ Bohlin, Jon; Eldholm, Vegard; Pettersson, John H. O.; Brynildsrud, Ola; Snipen, Lars (2017-02-10). "The nucleotide composition of microbial genomes indicates differential patterns of selection on core and accessory genomes". BMC Genomics. 18 (1): 151. Bibcode:2017BMCG...18..151B. doi:10.1186/s12864-017-3543-7. ISSN 1471-2164. PMC 5303225. PMID 28187704.
- 1 2 Pasolli, Edoardo; Mauriello, Italia Elisa; Avagliano, Michele; Cavaliere, Sara; Filippis, Francesca De; Ercolini, Danilo (2024-12-24). "Bifidobacteriaceae diversity in the human microbiome from a large-scale genome-wide analysis". Cell Reports. 43 (12) 115027. doi:10.1016/j.celrep.2024.115027. ISSN 2211-1247. PMID 39602306.
- 1 2 3 Isnard, Christophe; Lienhard, Reto; Reissier, Sophie; Rodriguez, Sonia; Krähenbühl, Joanna; Liassine, Nadia; Guérin, François; Cattoir, Vincent (2016-03-01). "In vitro antimicrobial susceptibility of Alloscardovia omnicolens and molecular mechanisms of acquired resistance". Diagnostic Microbiology and Infectious Disease. 84 (3): 227–229. doi:10.1016/j.diagmicrobio.2015.08.009. ISSN 0732-8893. PMID 26763712.
- ↑ Singh, Bishal; Christina, Evangeline (2021-01-01), "Chapter 11 - Bacterial metabolites: an unexplored quarry", in Kumar, Ajay; Singh, Joginder; Samuel, Jastin (eds.), Volatiles and Metabolites of Microbes, Academic Press, pp. 205–234, ISBN 978-0-12-824523-1, retrieved 2025-05-07